BTC$62,769.00-0.20%
ETH$1,795.23+0.98%
USDT$0.9988-0.02%
BNB$570.12+0.34%
USDC$0.9999+0.01%
XRP$1.07-0.75%
SOL$75.21-1.19%
TRX$0.3248-0.76%
FIGR_HELOC$1.03+1.91%
HYPE$63.84-1.72%
DOGE$0.0721-0.02%
USDS$0.9999+0.02%
RAIN$0.0142-1.58%
LEO$9.55+0.30%
ZEC$507.33-1.11%
WBT$55.10+0.04%
BTC$62,769.00-0.20%
ETH$1,795.23+0.98%
USDT$0.9988-0.02%
BNB$570.12+0.34%
USDC$0.9999+0.01%
XRP$1.07-0.75%
SOL$75.21-1.19%
TRX$0.3248-0.76%
FIGR_HELOC$1.03+1.91%
HYPE$63.84-1.72%
DOGE$0.0721-0.02%
USDS$0.9999+0.02%
RAIN$0.0142-1.58%
LEO$9.55+0.30%
ZEC$507.33-1.11%
WBT$55.10+0.04%
The latest earnings reports from T-Mobile, Kraft Heinz, and Humana reveal diverse performances and strategic focuses across different industries.
Humana stock fell more than 13% in premarket trading after the Trump administration proposed nearly flat Medicare Advantage payment rates for 2027.
Humana’s third-quarter results beat expectations with adjusted EPS of $3.24 and revenue of $32.65 billion, as the company reaffirmed its full-year EPS guidance.
Humana Inc. reports second quarter 2025 financial results with earnings per share (EPS) slightly below expectations.
Humana Inc. reports a strong first quarter of 2025 with adj. EPS exceeding expectations,
The decision to raise Medicare Advantage plan payments by over $25 billion has led to a positive response in the stock market.
Humana Inc. reported a net loss per share of $5.76 on a GAAP basis and an adjusted net loss per share of $2.16 for the fourth…
Cigna Group has decided not to merge with Humana, leading to a rise in Cigna's stock and a drop in Humana's stock.
Humana Inc. (NYSE: HUM) reported a strong third quarter in 2024, with GAAP earnings per share hitting $3.98 and adjusted EPS at $4.16.
Major stocks Tesla, Nike, and Humana face significant declines as Tesla misses delivery expectations, Nike withdraws guidance amid a CEO change, and Humana's Medicare quality ratings…
In a volatile trading session, Nike shares plunged nearly 20% following disappointing sales forecasts, while healthcare stocks Humana and UnitedHealth saw gains.
Humana withdrew its 2025 guidance due to Medicare Advantage uncertainties. Stock dropped over 5%.